← All stocks

VIEMED HEALTHCARE, INC.

VMD No buying or selling
CIK 0001729149 #3484 in the set updated 20 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

Ten years, as filed

8 years of statements
Figure 2018 2019 2020 2021 2022 2023 2024 2025
Revenue $64.46M $80.26M $131.31M $117.06M $138.83M $183.01M $224.26M $270.28M
Gross profit $47.78M $56.01M $80.11M $73.41M $84.68M $112.78M $133.20M $155.46M
Operating income $10.06M $8.86M $26.78M $11.58M $8.25M $14.33M $17.90M $22.95M
Net income $9.51M $8.53M $31.53M $9.13M $6.22M $10.24M $11.27M $14.93M
EPS diluted $0.24 $0.21 $0.78 $0.22 $0.16 $0.25 $0.28 $0.37
Operating cash flow $22.37M $19.09M $35.11M $22.49M $27.75M $45.21M $39.09M $51.92M
Capital expenditure $6.11M $13.39M $13.04M $19.74M $22.90M $26.09M $37.77M $39.99M
Free cash flow computed $16.25M $5.70M $22.07M $2.75M $4.85M $19.12M $1.32M $11.93M

By person

11 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Moore Michael
President
1,774,902
$20.80M
−4.7%
ZEHNDER WILLIAM TODD
Chief Operating Officer
390,309
$4.57M
+64.6%
Hoyt Casey
Chief Executive Officer
350,464
$4.11M
+69.4%
Kaushal Nitin
Director
161,361
$1.89M
+27.2%
Dobbs Randy E.
Director
142,253
$1.67M
+32.1%
Fitzgerald Trae
Chief Financial Officer
105,638
$1.24M
+50.9%
Cambre Jerome
Vice President of Sales
104,088
$1.22M
+34.2%
Smokoff Timothy
Director
90,547
$1.06M
−1.2%
Heltz Sabrina
Director
82,520
$967.13K
+59.4%
Frazier William
Chief Medical Officer
73,214
$858.07K
+8.0%
Trahan Jeremy
General Counsel
46,492
$544.89K
+319.2%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
0
no price
0
no price
0
no price
0
no price
0
no price
0
no price
0
no price
0
no price

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 6 Jan 2021